Cargando…
Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications
The global COVID-19 pandemic has disrupted every aspect of the healthcare system. Apart from the issues surrounding COVID-19 itself, care for existing patients has met many challenges. One such challenge is caring for patients who are on clozapine treatment and have been confirmed positive for COVID...
Autores principales: | Jeong, Seong Hoon, Kim, Yong Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316651/ https://www.ncbi.nlm.nih.gov/pubmed/34294611 http://dx.doi.org/10.9758/cpn.2021.19.3.411 |
Ejemplares similares
-
Clozapine prescribing and safety during COVID-19
por: Wadoo, Ovais, et al.
Publicado: (2021) -
Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020) -
Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018) -
Clozapine prescribing in COVID-19 positive medical inpatients: a case series
por: Butler, Matthew, et al.
Publicado: (2020) -
Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)